Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy
From MaRDI portal
Publication:2160715
Cites work
- A confidence building exercise in data and identifiability: modeling cancer chemotherapy as a case study
- A mathematical model of intermittent androgen suppression for prostate cancer
- A mathematical model of prostate tumor growth and androgen-independent relapse
- Analysis of mathematical model of prostate cancer with androgen deprivation therapy
- Comparison between mathematical models of intermittent androgen suppression for prostate cancer
- Determining identifiable parameter combinations using subset profiling
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
- Dynamics and implications of models for intermittent androgen suppression therapy
- Efficient data assimilation for spatiotemporal chaos: a local ensemble transform Kalman filter
- Identifiability and estimation of multiple transmission pathways in cholera and waterborne disease
- Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy
- On identifiability of nonlinear ODE models and applications in viral dynamics
- Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer
- Parameter identifiability and estimation of HIV/AIDS dynamic models
Cited in
(12)- A stochastic model for prostate-specific antigen levels
- Rich dynamics of a simple delay host-pathogen model of cell-to-cell infection for plant virus
- Predicting the effectiveness of chemotherapy using stochastic ODE models of tumor growth
- A study of disproportionately affected populations by race/ethnicity during the SARS-CoV-2 pandemic using multi-population SEIR modeling and ensemble data assimilation
- Dynamics of a non-smooth model of prostate cancer with intermittent androgen deprivation therapy
- Modeling the effect of immunotherapies on human castration-resistant prostate cancer
- An alternative approach to modelling relapse in cancer with an application to adenocarcinoma of the prostate
- Modeling of the pH- and the temperature-dependant deviations of the free to total PSA (prostate specific antigen) ratios for clinical predictability of prostate cancer and benign prostate hyperplasia
- Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer
- Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis
- Risk prediction for prostate cancer recurrence through regularized estimation with simultaneous adjustment for nonlinear clinical effects
- A joint-threshold Filippov model describing the effect of intermittent androgen-deprivation therapy in controlling prostate cancer
This page was built for publication: Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2160715)
